Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis.

Zinman, Bernard ; Ahrén, Bo LU ; Neubacher, Dietmar ; Patel, Sanjay ; Woerle, Hans-Juergen and Johansen, Odd Erik (2016) In Canadian Journal of Diabetes 40(1). p.50-57
Abstract
With the expanding armamentarium of noninsulin therapies for type 2 diabetes mellitus, the use of insulin with various oral agents is becoming more common. In this study, we assessed the efficacy and cardiovascular (CV) safety of the dipeptidyl peptidase-4 inhibitor linagliptin as add-on to insulin in patients with type 2 diabetes.
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Canadian Journal of Diabetes
volume
40
issue
1
pages
50 - 57
publisher
Elsevier
external identifiers
  • pmid:26474870
  • wos:000369170800011
  • scopus:84951036117
  • pmid:26474870
ISSN
2352-3840
DOI
10.1016/j.jcjd.2015.06.010
language
English
LU publication?
yes
id
5edf55df-2491-44a9-8d39-f6638d3233a1 (old id 8149135)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26474870?dopt=Abstract
date added to LUP
2016-04-01 10:59:06
date last changed
2025-04-04 15:09:04
@article{5edf55df-2491-44a9-8d39-f6638d3233a1,
  abstract     = {{With the expanding armamentarium of noninsulin therapies for type 2 diabetes mellitus, the use of insulin with various oral agents is becoming more common. In this study, we assessed the efficacy and cardiovascular (CV) safety of the dipeptidyl peptidase-4 inhibitor linagliptin as add-on to insulin in patients with type 2 diabetes.}},
  author       = {{Zinman, Bernard and Ahrén, Bo and Neubacher, Dietmar and Patel, Sanjay and Woerle, Hans-Juergen and Johansen, Odd Erik}},
  issn         = {{2352-3840}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{50--57}},
  publisher    = {{Elsevier}},
  series       = {{Canadian Journal of Diabetes}},
  title        = {{Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis.}},
  url          = {{http://dx.doi.org/10.1016/j.jcjd.2015.06.010}},
  doi          = {{10.1016/j.jcjd.2015.06.010}},
  volume       = {{40}},
  year         = {{2016}},
}